Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein

More about Open Access at the Crick


The CR3022 antibody, selected from a group of SARS-CoV monoclonal antibodies for its ability to cross-react with SARS-CoV-2, has been examined for its ability to bind to the ectodomain of the SARS-CoV-2 spike glycoprotein. Using cryo-electron microscopy we show that antibody binding requires rearrangements in the S1 domain that result in dissociation of the spike.

Journal details

Volume 11
Issue number 1
Pages 5337
Available online
Publication date